TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Developing and Validating Clinical Efficacy for Obesity Digital CBT Model
Brief Summary: The aim of the present study is to develop and validate the effects of a new cognitive behavioral therapy (CBT) using digital healthcare mobile apps such as Noom Coach and InBody.


Options:
A: Arm Label: Group 1. Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Group 2. Intervention 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention 1 | Arm Label: Group 2. Intervention 2; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention 2 | Intervention Type: BEHAVIORAL; Name: Intervention 1; Assigned to Arm(s): Group 2. Intervention 1 | Intervention Type: BEHAVIORAL; Name: Intervention 2; Assigned to Arm(s): Group 2. Intervention 2
B: Arm Label: Intensive digital CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Standard digital CBT; Type: ACTIVE_COMPARATOR; Interventions: Device: Self-guided | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): Intensive digital CBT | Intervention Type: DEVICE; Name: Self-guided; Assigned to Arm(s): Standard digital CBT
C: Arm Label: Online dietician lifestyle counseling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Online dietetic lifestyle counseling | Arm Label: Usual care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Online dietetic lifestyle counseling; Assigned to Arm(s): Online dietician lifestyle counseling | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual care
D: Arm Label: Intervention SG; Type: ACTIVE_COMPARATOR; Interventions: Device: PathMate2 | Arm Label: Control SG; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention VD; Type: ACTIVE_COMPARATOR; Interventions: Device: PathMateS | Arm Label: Control VD; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: PathMate2; Assigned to Arm(s): Intervention SG | Intervention Type: DEVICE; Name: PathMateS; Assigned to Arm(s): Intervention VD

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Antioxidant (Androferti) Treatment on Sperm DNA Integrity
Brief Summary: Increased sperm DNA Fragmentation Index implies decreased male fertility in vivo and in vitro. There is need for developing new strategies for improvement of male fertility. The study aims to investigate whether high sperm DNA Integration Index can be treated by use of antioxidants.


Options:
A: Arm Label: DHA plus vitamin E; Type: EXPERIMENTAL; Interventions: Dietary Supplement: vitamin E, Dietary Supplement: DHA | Arm Label: VitaminE plus placebo; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: vitamin E, Other: placebo | Arm Label: placebo plus placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Arm Label: DHA plus placebo; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: DHA, Other: placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin E; Assigned to Arm(s): DHA plus vitamin E, VitaminE plus placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: DHA; Assigned to Arm(s): DHA plus placebo, DHA plus vitamin E | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): DHA plus placebo, VitaminE plus placebo, placebo plus placebo
B: Arm Label: Antioxidant; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Androferti | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Androferti; Assigned to Arm(s): Antioxidant | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: High dose Vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Ergocalciferol | Arm Label: Low dose Vitamin D; Type: SHAM_COMPARATOR; Interventions: Dietary Supplement: Ergocalciferol | Intervention Type: DIETARY_SUPPLEMENT; Name: Ergocalciferol; Assigned to Arm(s): High dose Vitamin D | Intervention Type: DIETARY_SUPPLEMENT; Name: Ergocalciferol; Assigned to Arm(s): Low dose Vitamin D
D: Arm Label: Antioxidant Supplement; Type: ACTIVE_COMPARATOR; Interventions: Drug: Antioxidant Supplement | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Antioxidant Supplement; Assigned to Arm(s): Antioxidant Supplement | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of McGrath Videolaryngoscopy and Direct Laryngoscopy for Intubation in Patients With Morbid Obesity in Non-cardiac Surgery
Brief Summary: Our goal is to compare conventional direct laryngoscopy using a Macintosh blade with the McGrath videolaryngoscope for endotracheal intubation in very morbidly obese patients undergoing non-cardiac surgery. Specifically, we propose to test the primary hypotheses that videolaryngoscopy improves visualization of the vocal cords, defined with modified Cormack and Lehane classification, compared to direct laryngoscopy.


Options:
A: Arm Label: Glidescope; Type: ACTIVE_COMPARATOR; Interventions: Device: Endotracheal intubation | Arm Label: Macintosh laryngoscope; Type: ACTIVE_COMPARATOR; Interventions: Device: Endotracheal intubation | Arm Label: Bonfill's rigid scope; Type: ACTIVE_COMPARATOR; Interventions: Device: Endotracheal intubation | Arm Label: Air traq; Type: ACTIVE_COMPARATOR; Interventions: Device: Endotracheal intubation | Arm Label: C -Mac scope; Type: ACTIVE_COMPARATOR; Interventions: Device: Endotracheal intubation | Arm Label: flexible fiberoptic scope; Type: ACTIVE_COMPARATOR; Interventions: Device: Endotracheal intubation | Intervention Type: DEVICE; Name: Endotracheal intubation; Assigned to Arm(s): Air traq, Bonfill's rigid scope, C -Mac scope, Glidescope, Macintosh laryngoscope, flexible fiberoptic scope
B: Arm Label: GlideScope (GVL) Blade; Type: ACTIVE_COMPARATOR; Interventions: Device: Laryngoscopy with GlideScope (GVL) Blade | Arm Label: MacIntosh (MAC) Blade; Type: ACTIVE_COMPARATOR; Interventions: Device: Laryngoscopy with MacIntosh (MAC) Blade | Intervention Type: DEVICE; Name: Laryngoscopy with GlideScope (GVL) Blade; Assigned to Arm(s): GlideScope (GVL) Blade | Intervention Type: DEVICE; Name: Laryngoscopy with MacIntosh (MAC) Blade; Assigned to Arm(s): MacIntosh (MAC) Blade
C: Arm Label: McGrath videolaryngoscopy; Type: EXPERIMENTAL; Interventions: Device: McGrath videolaryngoscopy | Arm Label: Direct laryngoscopy; Type: ACTIVE_COMPARATOR; Interventions: Device: Direct laryngoscopy | Intervention Type: DEVICE; Name: McGrath videolaryngoscopy; Assigned to Arm(s): McGrath videolaryngoscopy | Intervention Type: DEVICE; Name: Direct laryngoscopy; Assigned to Arm(s): Direct laryngoscopy
D: Arm Label: Truview EVO2®; Type: ACTIVE_COMPARATOR; Interventions: Other: Macintosh type, Truview EVO2® type and Airtraq® type laryngoscopes | Arm Label: Airtraq®; Type: ACTIVE_COMPARATOR; Interventions: Other: Macintosh type, Truview EVO2® type and Airtraq® type laryngoscopes | Arm Label: Direct laryngoscopy; Type: ACTIVE_COMPARATOR; Interventions: Other: Macintosh type, Truview EVO2® type and Airtraq® type laryngoscopes | Intervention Type: OTHER; Name: Macintosh type, Truview EVO2® type and Airtraq® type laryngoscopes; Assigned to Arm(s): Airtraq®, Direct laryngoscopy, Truview EVO2®

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicentre, Double Blind, Randomised Sham-Controlled Trial of 10kHz High-Frequency Spinal Cord Stimulation for Chronic Neuropathic Low Back Pain (Modulate-LBP)
Brief Summary: Multicentre, randomised, double-blinded, sham-controlled trial with parallel economic evaluation. Patients will be allocated 1:1 to activated 10kHz SCS plus usual care (intervention) or sham 10kHz SCS plus usual care (control) and followed up to 6 months.


Options:
A: Arm Label: Active Lead (AL); Type: ACTIVE_COMPARATOR; Interventions: Device: Nevro Senza System (HF10 Therapy) | Arm Label: Sham Lead (SL); Type: SHAM_COMPARATOR; Interventions: Device: Nevro Senza System (HF10 Therapy) | Intervention Type: DEVICE; Name: Nevro Senza System (HF10 Therapy); Assigned to Arm(s): Active Lead (AL), Sham Lead (SL)
B: Arm Label: Burst spinal cord stimulation (SCS); Type: EXPERIMENTAL; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Arm Label: sham spinal cord stimulation (SCS); Type: SHAM_COMPARATOR; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Intervention Type: PROCEDURE; Name: Burst Spinal Cord Stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS) | Intervention Type: PROCEDURE; Name: Sham spinal cord stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS)
C: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Device: PINS Spinal Cord Stimulator | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Device: PINS Spinal Cord Stimulator | Intervention Type: DEVICE; Name: PINS Spinal Cord Stimulator; Assigned to Arm(s): Control, Experimental
D: Arm Label: scs high-frequency; Type: EXPERIMENTAL; Interventions: Device: Device: Precision Novi™ system Neurostimulation procedures | Arm Label: scs tonic; Type: EXPERIMENTAL; Interventions: Device: Device: Precision Novi™ system Neurostimulation procedures | Arm Label: scs burst; Type: EXPERIMENTAL; Interventions: Device: Device: Precision Novi™ system Neurostimulation procedures | Arm Label: scs off; Type: PLACEBO_COMPARATOR; Interventions: Device: Device: Precision Novi™ system Neurostimulation procedures | Intervention Type: DEVICE; Name: Device: Precision Novi™ system Neurostimulation procedures; Assigned to Arm(s): scs burst, scs high-frequency, scs off, scs tonic

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicentre, Double Blind, Randomised Sham-Controlled Trial of 10kHz High-Frequency Spinal Cord Stimulation for Chronic Neuropathic Low Back Pain (Modulate-LBP)
Brief Summary: Multicentre, randomised, double-blinded, sham-controlled trial with parallel economic evaluation. Patients will be allocated 1:1 to activated 10kHz SCS plus usual care (intervention) or sham 10kHz SCS plus usual care (control) and followed up to 6 months.


Options:
A: Arm Label: SHAM; Type: SHAM_COMPARATOR; Interventions: Device: Spinal cord stimulation | Arm Label: High Density Stimulation; Type: EXPERIMENTAL; Interventions: Device: Spinal cord stimulation | Arm Label: Conventional stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal cord stimulation | Intervention Type: DEVICE; Name: Spinal cord stimulation; Assigned to Arm(s): Conventional stimulation, High Density Stimulation, SHAM
B: Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Sham | Arm Label: 1200 Hz; Type: EXPERIMENTAL; Interventions: Device: 1200 Hz | Arm Label: 3030 Hz; Type: EXPERIMENTAL; Interventions: Device: 3030 Hz | Arm Label: 5882 Hz; Type: EXPERIMENTAL; Interventions: Device: 5882 Hz | Intervention Type: DEVICE; Name: Sham; Assigned to Arm(s): Sham | Intervention Type: DEVICE; Name: 1200 Hz; Assigned to Arm(s): 1200 Hz | Intervention Type: DEVICE; Name: 3030 Hz; Assigned to Arm(s): 3030 Hz | Intervention Type: DEVICE; Name: 5882 Hz; Assigned to Arm(s): 5882 Hz
C: Intervention Type: DEVICE; Name: Medtronic Manufactured Spinal Cord Stimulators; Assigned to Arm(s): N/A
D: Arm Label: Active Lead (AL); Type: ACTIVE_COMPARATOR; Interventions: Device: Nevro Senza System (HF10 Therapy) | Arm Label: Sham Lead (SL); Type: SHAM_COMPARATOR; Interventions: Device: Nevro Senza System (HF10 Therapy) | Intervention Type: DEVICE; Name: Nevro Senza System (HF10 Therapy); Assigned to Arm(s): Active Lead (AL), Sham Lead (SL)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicentre, Double Blind, Randomised Sham-Controlled Trial of 10kHz High-Frequency Spinal Cord Stimulation for Chronic Neuropathic Low Back Pain (Modulate-LBP)
Brief Summary: Multicentre, randomised, double-blinded, sham-controlled trial with parallel economic evaluation. Patients will be allocated 1:1 to activated 10kHz SCS plus usual care (intervention) or sham 10kHz SCS plus usual care (control) and followed up to 6 months.


Options:
A: Arm Label: CMM; Type: OTHER; Interventions: Other: CMM | Arm Label: HF10 + CMM; Type: ACTIVE_COMPARATOR; Interventions: Device: HF10 Therapy, Other: CMM | Intervention Type: DEVICE; Name: HF10 Therapy; Assigned to Arm(s): HF10 + CMM | Intervention Type: OTHER; Name: CMM; Assigned to Arm(s): CMM, HF10 + CMM
B: Arm Label: Study sequence A; Type: EXPERIMENTAL; Interventions: Device: Proclaim™ Elite 5: Burst - Washout - Sham | Arm Label: Study sequence B; Type: EXPERIMENTAL; Interventions: Device: Proclaim™ Elite 5: Sham - Washout - Burst | Intervention Type: DEVICE; Name: Proclaim™ Elite 5: Burst - Washout - Sham; Assigned to Arm(s): Study sequence A | Intervention Type: DEVICE; Name: Proclaim™ Elite 5: Sham - Washout - Burst; Assigned to Arm(s): Study sequence B
C: Arm Label: Active Lead (AL); Type: ACTIVE_COMPARATOR; Interventions: Device: Nevro Senza System (HF10 Therapy) | Arm Label: Sham Lead (SL); Type: SHAM_COMPARATOR; Interventions: Device: Nevro Senza System (HF10 Therapy) | Intervention Type: DEVICE; Name: Nevro Senza System (HF10 Therapy); Assigned to Arm(s): Active Lead (AL), Sham Lead (SL)
D: Arm Label: Group A - active treatment; Type: EXPERIMENTAL; Interventions: Device: Spinal cord stimulation by implanted device. | Arm Label: Group B - conservative management; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Spinal cord stimulation by implanted device.; Assigned to Arm(s): Group A - active treatment

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase IIa, Randomized, Double-blind, Placebo-controlled Study to Evaluate GLPG2737 in Orkambi-treated Subjects With Cystic Fibrosis Homozygous for the F508del Mutation
Brief Summary: This is a Phase IIa, multi-center, randomized, double-blind, placebo-controlled, parallel-group study to evaluate GLPG2737 administered orally b.i.d. for 28 days to adult male and female subjects with a confirmed diagnosis of cystic fibrosis homozygous for the F508del CFTR mutation and on stable treatment with Orkambi.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: VX-809, 25 mg; Type: EXPERIMENTAL; Interventions: Drug: VX-809 | Arm Label: VX-809, 50 mg; Type: EXPERIMENTAL; Interventions: Drug: VX-809 | Arm Label: VX-809, 100 mg; Type: EXPERIMENTAL; Interventions: Drug: VX-809 | Arm Label: VX-809, 200 mg; Type: EXPERIMENTAL; Interventions: Drug: VX-809 | Intervention Type: DRUG; Name: VX-809; Assigned to Arm(s): VX-809, 100 mg, VX-809, 200 mg, VX-809, 25 mg, VX-809, 50 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: VX-661 Plus Ivacaftor Combination Placebo, Drug: Ivacaftor placebo | Arm Label: VX-661/IVA; Type: EXPERIMENTAL; Interventions: Drug: VX-661 Plus Ivacaftor Combination, Drug: Ivacaftor | Intervention Type: DRUG; Name: VX-661 Plus Ivacaftor Combination; Assigned to Arm(s): VX-661/IVA | Intervention Type: DRUG; Name: Ivacaftor; Assigned to Arm(s): VX-661/IVA | Intervention Type: DRUG; Name: VX-661 Plus Ivacaftor Combination Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Ivacaftor placebo; Assigned to Arm(s): Placebo
C: Arm Label: Riociguat (Adempas, BAY63-2521); Type: EXPERIMENTAL; Interventions: Drug: Riociguat (Adempas, BAY63-2521) | Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Riociguat (Adempas, BAY63-2521); Assigned to Arm(s): Riociguat (Adempas, BAY63-2521) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: GLPG2737; Type: EXPERIMENTAL; Interventions: Drug: GLPG2737 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: GLPG2737; Assigned to Arm(s): GLPG2737 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II/III, Multicenter, Open-Label, Randomized Study of Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India
Brief Summary: This study has been designed to compare the liquid formulation of BRV-PV (LBRV-PV) with the lyophilized formulation (ROTASIIL) by testing the vaccine in infants (three doses administered 4 weeks apart, starting at 6-8 weeks of age) in order to demonstrate the non-inferiority in the induction of specific anti-rotavirus IgA antibodies by these vaccines. The study will also evaluate lot-to-lot consistency in the manufacture of LBRV-PV by demonstrating equivalence in the induction of specific anti-rotavirus IgA antibodies across three production lots.


Options:
A: Arm Label: Primary 1: Rotavirus vaccine 6 and 10 weeks; Type: ACTIVE_COMPARATOR; Interventions: Biological: Rotavirus vaccine | Arm Label: Primary 1: Rotavirus vaccine 6, 10 and 14 weeks; Type: EXPERIMENTAL; Interventions: Biological: Rotavirus vaccine | Arm Label: Primary 1: Rotavirus vaccine 10 and 14 weeks; Type: EXPERIMENTAL; Interventions: Biological: Rotavirus vaccine | Arm Label: Primary 2: Rotavirus vaccine withholding breast feeding; Type: EXPERIMENTAL; Interventions: Biological: Rotavirus vaccine | Arm Label: Primary 2: Rotavirus vaccine with immediate breast feeding; Type: EXPERIMENTAL; Interventions: Biological: Rotavirus vaccine | Arm Label: Baseline seroconversion for rotavirus; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BIOLOGICAL; Name: Rotavirus vaccine; Assigned to Arm(s): Primary 1: Rotavirus vaccine 10 and 14 weeks, Primary 1: Rotavirus vaccine 6 and 10 weeks, Primary 1: Rotavirus vaccine 6, 10 and 14 weeks, Primary 2: Rotavirus vaccine with immediate breast feeding, Primary 2: Rotavirus vaccine withholding breast feeding
B: Intervention Type: BIOLOGICAL; Name: HRV vaccine; Assigned to Arm(s): N/A
C: Intervention Type: BIOLOGICAL; Name: Rotavirus (vaccine); Assigned to Arm(s): N/A
D: Arm Label: LBRV-PV Lot A; Type: EXPERIMENTAL; Interventions: Biological: Liquid Rotavirus Vaccine | Arm Label: LBRV-PV Lot B; Type: EXPERIMENTAL; Interventions: Biological: Liquid Rotavirus Vaccine | Arm Label: LBRV-PV Lot C; Type: EXPERIMENTAL; Interventions: Biological: Liquid Rotavirus Vaccine | Arm Label: ROTASIIL; Type: ACTIVE_COMPARATOR; Interventions: Biological: Liquid Rotavirus Vaccine | Intervention Type: BIOLOGICAL; Name: Liquid Rotavirus Vaccine; Assigned to Arm(s): LBRV-PV Lot A, LBRV-PV Lot B, LBRV-PV Lot C, ROTASIIL

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Internet-Based Intervention for Occupational Stress Among Medical Professionals: A Randomized Controlled Trial
Brief Summary: The aim of this study is to assess the efficacy of internet intervention for reduction of occupational stress and its negative consequences (job burnout, depression) among medical professionals through the enhancement of the resources that are critical for coping with stress: self-efficacy and perceived social support.


Options:
A: Arm Label: Immediate Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Mindful-Compassion Art Therapy for Dementia Care (MCAT-DC) | Arm Label: Waitlist Control Group; Type: EXPERIMENTAL; Interventions: Behavioral: Mindful-Compassion Art Therapy for Dementia Care (MCAT-DC) | Intervention Type: BEHAVIORAL; Name: Mindful-Compassion Art Therapy for Dementia Care (MCAT-DC); Assigned to Arm(s): Immediate Intervention Group, Waitlist Control Group
B: Arm Label: Mental Training for Surgeons; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness Based Stress Reduction - modified | Arm Label: The Mind of a Surgeon; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active listening and reading | Intervention Type: BEHAVIORAL; Name: Mindfulness Based Stress Reduction - modified; Assigned to Arm(s): Mental Training for Surgeons | Intervention Type: BEHAVIORAL; Name: Active listening and reading; Assigned to Arm(s): The Mind of a Surgeon
C: Arm Label: Self-Efficacy and Perceived Social Support; Type: EXPERIMENTAL; Interventions: Behavioral: Personal resources' enhancement: self-efficacy and perceived social support | Arm Label: Perceived Social Support and Self-Efficacy; Type: EXPERIMENTAL; Interventions: Behavioral: Personal resources' enhancement: perceived social support and self-efficacy | Arm Label: Self-Efficacy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Personal resources' enhancement: self-efficacy | Arm Label: Perceived Social Support; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Personal resources' enhancement: perceived social support | Intervention Type: BEHAVIORAL; Name: Personal resources' enhancement: self-efficacy and perceived social support; Assigned to Arm(s): Self-Efficacy and Perceived Social Support | Intervention Type: BEHAVIORAL; Name: Personal resources' enhancement: perceived social support and self-efficacy; Assigned to Arm(s): Perceived Social Support and Self-Efficacy | Intervention Type: BEHAVIORAL; Name: Personal resources' enhancement: self-efficacy; Assigned to Arm(s): Self-Efficacy | Intervention Type: BEHAVIORAL; Name: Personal resources' enhancement: perceived social support; Assigned to Arm(s): Perceived Social Support
D: Arm Label: Group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Manualized Therapy | Arm Label: Control Group; Type: OTHER; Interventions: Behavioral: Control Group | Intervention Type: BEHAVIORAL; Name: Manualized Therapy; Assigned to Arm(s): Group therapy | Intervention Type: BEHAVIORAL; Name: Control Group; Assigned to Arm(s): Control Group

Answer: C